Rani Therapeutics Holdings, Inc. (RANI) — DEFA14A Filings
All DEFA14A filings from Rani Therapeutics Holdings, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Rani Therapeutics Files Proxy Supplement for May 28 Meeting
— Apr 30, 2025 Risk: low
Rani Therapeutics Holdings, Inc. filed a Definitive Additional Materials proxy statement on April 30, 2025, supplementing its proxy statement for the Annual Mee
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX